Lipoprotein-associated phospholipase A2 (Lp-PLA2 ) and high sensitivity C-reactive protein (hsCRP) levels, and extends coronary artery disease (CAD) patient after one year observation
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.